Neoprobe Corporation Completes Senior Debt and Preferred Stock Exchanges

DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative biomedical surgical oncology products, today announced that Platinum-Montaur Life Sciences, LLC (Montaur) has agreed to exchange all $10 million of its outstanding 10% senior secured convertible notes and $3 million perpetual convertible preferred stock for a single new series of preferred stock convertible into common shares of Neoprobe Corporation. This transaction significantly strengthens the Company’s balance sheet and positions Neoprobe for an eventual listing on a major national stock exchange.